During the past decade, North Texas Clinical Research conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "North Texas Clinical Research" #1 sponsor was "AstraZeneca" with 5 trials, followed by "Concert Pharmaceuticals" with 2 trials sponsored, "Gilead Sciences" with 2 trials sponsored, "Pfizer" with 1 trials sponsored and "Q32 Bio Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

According to Clinical.Site data, the most researched conditions in "North Texas Clinical Research" are "Alopecia Areata" (3 trials), "Atopic Dermatitis" (2 trials), "Diabetes Mellitus, Non-Insulin-Dependent" (2 trials), "Chronic Spontaneous Urticaria" (1 trials) and "Diabetes Mellitus, Type 1" (1 trials). Many other conditions were trialed in "North Texas Clinical Research" in a lesser frequency.

Most popular intervention types in "North Texas Clinical Research" are "Drug" (10 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "AC2993" (4 trials), "ADX-914" (1 trials), "CTP-543" (1 trials) and "CTP-543, 12 mg BID" (1 trials). Other intervention names were less common.

The vast majority of trials in "North Texas Clinical Research" are 12 trials for "All" genders.

Currently, there are NaN active trials in "North Texas Clinical Research". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 8 completed trials in North Texas Clinical Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in North Texas Clinical Research, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".